Director/PDMR Shareholding

RNS Number : 9399S
GlaxoSmithKline PLC
22 March 2016
 

GlaxoSmithKline plc

 

Notification of Transactions of Directors, Persons Discharging Managerial Responsibility or Connected Persons

 

 

In accordance with DTR 3.1.4R (1) (a) I give details of changes in the interests of Roger Connor, a Person Discharging Managerial Responsibility, in the Ordinary Shares of GlaxoSmithKline plc (the "Company") following:

 

1.   the exercise of a nil cost option over 3,680 Ordinary Shares on 22 March 2016, granted on 28 February 2013, which vested on 28 February 2016 under the GlaxoSmithKline Deferred Annual Bonus Plan;

 

2.   the sale of 3,680 Ordinary shares on 22 March 2016 at a price of £13.78 per share; and

 

3.   the sale of 19,320 Ordinary Shares on 22 March 2016 at a price of £13.76 per share.

 

 

The Company and Mr Connor were advised of these transactions on 22 March 2016.

 

 

V A Whyte

Company Secretary

 

22 March 2016

 


This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RDSELLFLQXFFBBX

Companies

GSK (GSK)
UK 100